Sujatha Biotech plans expansion

Image
BS Reporter Chennai
Last Updated : Jan 20 2013 | 7:32 PM IST

Chennai-based Sujatha Biotech, a healthcare and functional food products manufacturer, is planning a pan-India expansion and export of its products through a marketing tieup with Kunnath Pharmaceuticals based in Kerala. The company is also planning to go public with an IPO during fiscal 2011-12 to support its future expansion plans.

As per the agreement, Kunnath Pharma, which presently sells its herbal revitaliser Musli Power Xtra through some 250,000 retail outlets, will market Sujatha Biotech’s products through its distribution channels. Kunnath Pharmaceuticals presently addresses 150,000 retail outlets directly and another around 100,000 outlets indirectly.

With the tieup, we expect to address nearly 40 per cent of the FMCG (fast moving consumer goods) healthcare market in India, said C K Rajkumar, mentor and founder of Sujatha Biotech Ltd. At present, there are 1 million FMCG shops in India and 10 per cent of the products marketed through these shops are related to healthcare, he added.

The alliance is expected to boost sales of the company’s functional food products, memory enhancing health drink and cereal — Memory Vita and herbal healthare product Memory Plus capsules across the country.

The company recently initiated a brand building exercise for its products by roping in cricketer M S Dhoni as brand ambassador. As part of its publicity initiative, it would spend around Rs 7 crore in brand building through advertisements in the near future. It expects to grab 3-4 per cent of the Rs 3,000 crore beverages market in India in next two years, he added.

It is also registering the capsule product with the regulatory authorities in Singapore and Malaysia and is expecting to market to these countries in around 3 months.

With the capsule claims to have clinically-proven to enhance memory, the product needs regulatory clearance from food and drug regulatory authorities of different countries for marketing.

With the initiatives, the Rs 30 crore Sujatha Biotech expects to double its revenues by 2012. It also plans to enter stock market in the fiscal 2011-12 through Initial Public Offering to raise funds for future expansion plans, said Rajkumar. The company would expand its market for the functional food products to European Union in future.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 06 2011 | 12:03 AM IST

Next Story